
Euromedgroup
About Euromedgroup
Euromedgroup is a Healthcare company, and was acquired by Dermapharm in January 2019. Manufacturer of standardized herbal extracts and botanical active ingredients. Its focus areas include Alternative Medicine Products. Its legal entity is Euromed S.A.
Company details
Standardized herbal extracts and botanical active ingredients are produced by Euromedgroup for pharmaceutical, nutraceutical, food, pet care, and cosmetic sectors. Botanical raw materials are sourced and processed under Good Agricultural and Collection Practices (GACP) guidelines, including organic standards. Extracts from Mediterranean fruits and vegetables are developed using water-based technology, alongside traditional botanicals. Emphasis is placed on research and development to deliver traceable, quality-controlled products meeting industry requirements.
- Stage Acquired
- SectorsHealthcare
- Website euromedgroup.com
- Acquired by Dermapharm (Jan 2019)
- Legal Name Euromed S.A.
- InvestorsDermapharm
& 1 more
- Acquired by
Investors in Euromedgroup
Euromedgroup has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Dermapharm and The Riverside Company.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity and debt are provided to middle market companies. | riversidecompany.com | Cleveland, United States | ||
Dermatological and pharmaceutical medications are developed and manufactured. | 1991 | dermapharm.de | Grunwald, Germany |
Investor details for Euromedgroup
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Euromedgroup
2 dated milestones of Euromedgroup across 4 years, from founding to its latest funding, stage changes and deals.
- Exit Acquired by Riverside.
- Exit Acquired by Dermapharm.
Web traffic of Euromedgroup
The website of Euromedgroup (euromedgroup.com) receives about 3.7K visits a month.
- Monthly visits3.7K
▲ 25.8% vs previous month
Websites whose visitors overlap most with Euromedgroup. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
bickfordflavors.com | bickfordflavors.com | 100% | #2,043,377 | β | |
| inolex.com | 94% | 7.9K | #2,884,141 | View details | |
valleyfig.com | valleyfig.com | 88% | #881,200 | β |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Euromedgroup
Standardized herbal extracts and botanical active ingredients are produced by Euromedgroup for pharmaceutical, nutraceutical, food, pet care, and cosmetic sectors. Botanical raw materials are sourced and processed under Good Agricultural and Collection Practices (GACP) guidelines, including organic standards. Extracts from Mediterranean fruits and vegetables are developed using water-based technology, alongside traditional botanicals. Emphasis is placed on research and development to deliver traceable, quality-controlled products meeting industry requirements.
Euromedgroup has 2 investors. Key investors include Dermapharm, and The Riverside Company.
Euromedgroup operates through Euromed S.A..
Yes. Euromedgroup was acquired by Dermapharm in January 2019.